Ascendis Health, which had debt problems that led to a 95% fall in its share price over the past three years, is optimistic that much of its business will continue to benefit from health-care demand as a result of Covid-19.

On balance, the Ascendis portfolio may be regarded as “Covid-19 defensive”, the group said in an update on Tuesday, which is important as it seeks to improve the value of assets it is looking to sell as it grapples with a debt pile almost 20 times its market capitalisation...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now